News - Gilead Sciences, AbbVie

Filter

Current filters:

Gilead SciencesAbbVie

Popular Filters

Drug pricing power led by hepatitis C, diabetes and cancer

Drug pricing power led by hepatitis C, diabetes and cancer

13-06-2014

Hepatitis C, diabetes and cancer are sustaining high pricing power through innovation according to Morningstar's…

AbbVieAntibiotics and Infectious diseasesBiogen IdecCopaxoneDiabetesGenericsGilead SciencesMerck & CoOncologyPharmaceuticalPricingTecfideraTeva Pharmaceutical IndustriesUSA

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top